Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glycosaminoglycan (GAG) layer is a specialized carbohydrate-rich coating on the luminal surface of the bladder urothelium. It comprises proteoglycans with GAG chains such as heparan sulfate, chondroitin sulfate, dermatan sulfate, and hyaluronic acid. This layer acts as a protective barrier against pathogens, toxins, and mechanical injury. In bladder cancer, alterations in GAG composition correlate with invasiveness, tumor grade, and prognosis, making it a potential diagnostic and therapeutic target.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycosaminoglycan Layer (GAG Layer).